Regarding γ' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity

Blood Cells Mol Dis. 2024 Mar:105:102826. doi: 10.1016/j.bcmd.2024.102826. Epub 2024 Jan 17.

Authors

Sangsang Wang¹, Diao Yu², Junwu Zhang³

Affiliations

¹ Department of Clinical Laboratory, Ningbo Ninth Hospital, Ningbo, China.
² Department of Clinical Laboratory, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China. Electronic address: [email protected].
³ Department of Clinical Laboratory, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, China. Electronic address: [email protected].

PMID: 38262103
DOI: 10.1016/j.bcmd.2024.102826

No abstract available

Keywords: Biomarker; COVID-19 respiratory disease severity; γ′ fibrinogen levels.

Publication types

Letter
Comment

MeSH terms

Biomarkers
Blood Coagulation Tests
COVID-19* / diagnosis
Fibrinogen*
Humans
Risk Factors

Substances

Fibrinogen
Biomarkers